查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829257

2025年全球辅助人工心臟市场报告

Ventricular Assist Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，辅助人工心臟的市场规模迅速扩张，从2024年的21.2亿美元成长到2025年的23.7亿美元，复合年增长率为11.8%。预测期内的成长主要源自于心臟衰竭盛行率的上升以及器官移植手术需求的不断增加。

预计未来几年辅助人工心臟市场将快速成长，到2029年将达到38.7亿美元，年复合成长率（CAGR）为13.0%。预测期内的增长可归因于对目的地治疗的需求不断增长、人口老化、医疗保健支出不断增加以及人们对心臟衰竭治疗认识的提高。预测期内的主要趋势包括：延长辅助人工心臟的使用寿命、辅助人工心臟的小型化、泵浦技术的进步、对心室辅助装置安全性和有效性的日益关注、减少辅助人工心臟的副作用以及经皮置入心室辅助人工心臟。

辅助人工心臟(辅助人工心臟) 是一种植入式机械循环装置，可透过辅助全身血液循环并支持重要器官功能来治疗心臟衰竭。美国FDA 已核准多种类型的辅助人工心臟 ，为末期心臟衰竭患者提供长期或永久性支援。

辅助人工心臟的主要类型包括左心室辅助人工心臟(LVAD)、右心室辅助人工心臟(RVAD) 和双心室辅助人工心臟(BIVAD)。 LVAD 是一种电池供电的机械泵，用于将血液从左心室泵送到重要器官。 LVAD 的设计范围从经皮到植入式，并采用各种流动机制，包括脉动流和连续流。这些辅助人工心臟用途广泛，包括移植桥接 (BTT) 治疗、最终治疗、復健桥接 (BTR) 治疗和候选桥接 (BTC) 治疗。辅助人工心臟装置的最终使用者包括医院、门诊手术中心和心臟中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司新报告系列的一部分，该系列提供辅助人工心臟辅助人工心臟统计数据，例如全球市场规模、区域份额、辅助人工心臟市场份额的竞争对手、详细的心臟辅助设备细分市场、市场趋势和商业机会，以及在辅助人工心臟辅助人工心臟取得成功所需的数据。这份辅助人工心臟市场研究报告对该行业的当前和未来情况进行了详细的分析，为您提供所需的一切的完整观点。

未来五年的预测成长率为13.0%，较我们先前对该市场的预测略有下降0.1%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接影响到美国，导致来自瑞典和英国等主要地区的生物相容性血泵叶轮和经皮传动系统部件的供应链中断，从而可能导致挽救生命的心臟衰竭支持系统短缺。

心血管疾病发生率的上升推动了辅助人工心臟市场的成长。心血管疾病，包括由高血压、吸烟、高胆固醇和缺乏运动等因素引起的心臟病，正变得越来越普遍。糖尿病、慢性呼吸系统疾病和高血压相关心臟病等非传染性疾病进一步加剧了这些疾病的流行。随着心血管疾病发生率的上升，对辅助人工心臟是重症心臟病患者的重要支持系统。例如，美国联邦机构国家医学图书馆在2022年10月预测，到2035年，45.1%的美国人口将罹患心血管疾病，这些疾病相关的总费用将达到1.1兆美元。因此，预计心血管疾病发生率的上升将在预测期内显着推动对辅助人工心臟的需求。

提高对心臟衰竭治疗的认识是预计推动辅助人工心臟市场成长的关键因素。心臟衰竭的特征是心臟有效泵血能力下降，由冠状动脉疾病、心臟病发作、高血压和心肌损伤等疾病引起。提高对心臟衰竭治疗的认识预计将推动辅助人工心臟作为治疗心臟衰竭的一种手段。值得注意的是，美国心臟协会预测，到 2030 年，心臟衰竭诊断率将增加 46%，受影响人数将超过 800 万人。随着心臟衰竭确诊人数的持续增加，对可用治疗方案的认识不断提高预计将成为辅助人工心臟市场的主要驱动力。

经皮经皮辅助人工心臟)在市场上越来越受欢迎。 VAD 是一种非搏动性轴流泵，放置在主动脉瓣上，用于从左心室泵血。这些装置可以减轻左心室的负荷，降低心肌耗氧消费量，增加心抟出量，并降低左心室舒张末期压力。例如，2022 年 8 月，美国医疗设备美国Abiomed 推出了专为符合条件的经皮患者设计的 Impella 经皮辅助人工心臟提供有效的心臟支持以补偿衰竭的左心室，可以作为体外膜氧气疗法(ECMO) 的替代方案或补充其他疗法以改善血流动力学。

2022年8月，总部位于爱尔兰的医疗设备製造商美Medtronic PLC）以9.25亿美元收购了Affera公司。此次策略性收购扩大了Medtronic的心导管电气烧灼术产品组合，并推出了其首个心臟定位和导航平台，该平台包括射频消融、局部脉衝磁场治疗和整合诊断解决方案。 Affera公司是一家总部位于美国的医疗科技公司，专注于心臟定位和导航系统以及基于导管的心导管电气烧灼术技术。

参与辅助人工心臟市场的主要企业包括 Abiomed、雅培实验室、美敦力、LivaNova PLC、Terumo Corporation、Berlin Heart GmbH、Cirtec、Jarvik Heart、SynCardia Systems LLC、Calon Cardio-Technology Ltd、美国医学有限公司、 Inc.、BiVACOR Inc.、ReliantHeart Inc.、Cardiac Assist Inc.、Heart Ware International 和 Braille Biomedica Ltd.。

2024年，北美是辅助人工心臟市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。辅助人工心臟市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

辅助人工心臟市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、美国、义大利、西班牙和加拿大。

辅助人工心臟市场包括搏动式和非搏动式左心室辅助装置 (LVAD) 的销售。该市场的价值为“出厂价”，即商品製造商或生产商销售的商品价值，无论是销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）还是直接销售给最终客户。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球辅助人工心臟：PESTEL 分析（政治、社会、技术、环境、法律、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球辅助人工心臟市场：成长率分析
  • 全球辅助人工心臟市场表现：规模与成长，2019-2024
  • 全球辅助人工心臟市场预测：规模与成长，2024-2029年，2034年
  • 全球辅助人工心臟：总潜在市场（TAM）

第六章 市场细分

  • 全球辅助人工心臟市场：依产品、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 左心室辅助装置（LVAD）
  • 右心室辅助装置（RVAD）
  • 双心室辅助装置（BIVAD）
  • 全球辅助人工心臟市场类型、表现及预测（2019-2024 年、2024-2029 年、2034 年）
  • 脉动流
  • 连续流
  • 全球辅助人工心臟市场：设计、性能及预测（2019-2024、2024-2029、2034）
  • 经皮心室辅助装置
  • 植入式辅助人工心臟
  • 全球辅助人工心臟市场：应用、效能及预测，2019-2024年、2024-2029年、2034年
  • 移植前桥接（BTT）治疗
  • 目的地疗法
  • 復健桥樑疗法（BTR）
  • 候选人资格桥樑（BTC）治疗
  • 全球辅助人工心臟市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 心臟病中心
  • 全球左心室辅助人工心臟市场：左心室辅助人工心臟（LVAD）细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 植入式左心室辅助装置
  • 暂时 LVAD
  • 全球右心室辅助人工心臟装置（RVAD）市场：细分、类型、绩效及预测，2019-2024年、2024-2029年、2034年
  • 植入式右心室辅助装置
  • 临时 RVAD
  • 全球双心室辅助人工心臟装置 (BIVAD) 市场：细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 全力支持BIVAD
  • 混合型双侧输尿管假体

第七章 区域和国家分析

  • 全球辅助人工心臟市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球辅助人工心臟市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 辅助人工心臟市场：竞争格局
  • 辅助人工心臟市场：公司简介
    • Abiomed
    • Abbott Laboratories
    • Medtronic
    • LivaNova PLC
    • Terumo Corporation

第31章：其他领先和创新企业

  • Berlin Heart GmbH
  • Cirtec
  • Jarvik Heart Inc.
  • SynCardia Systems LLC.
  • Calon Cardio-Technology Ltd
  • Huadong Medicine Co. Ltd
  • Shenzhen Hexin Zondan Medical Equipment Co. Ltd
  • Sun Medical Technology Research Corp.
  • Boston Scientific Corporation
  • CorWave SA
  • CH生物医学（美国）公司
  • Evaheart Inc
  • BiVACOR Inc
  • ReliantHeart Inc
  • Cardiac Assist Inc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年辅助人工心臟市场：提供新机会的国家
  • 2029年辅助人工心臟市场：细分市场带来新机会
  • 辅助人工心臟市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r26022u

A ventricular assist device (VAD) is an implantable mechanical circulatory device used to treat heart failure by aiding blood circulation throughout the body, supporting vital organ function. The US FDA has approved a diverse range of VADs, offering long-term or permanent assistance for patients with end-stage heart failure.

The primary types of VADs include left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). LVADs, battery-operated mechanical pumps, help propel blood from the left ventricle to vital organs. They vary in design as transcutaneous or implantable devices and operate with different flow mechanisms such as pulsatile flow and continuous flow. These devices are used for various purposes including bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. End-users of VADs include hospitals, ambulatory surgical centers, and cardiology centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The ventricular assist device market research report is one of a series of new reports from The Business Research Company that provides ventricular assist device market statistics, including ventricular assist device industry global market size, regional shares, competitors with a ventricular assist device market share, detailed ventricular assist device market segments, market trends and opportunities, and any further data you may need to thrive in the ventricular assist device industry. This ventricular assist device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ventricular assist device market size has grown rapidly in recent years. It will grow from $2.12 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to an increase in the prevalence of heart failure and a rise in demand for organ transplantation procedures.

The ventricular assist device market size is expected to see rapid growth in the next few years. It will grow to $3.87 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to the increasing need for destination therapy, aging population, increasing healthcare expenditure and a rise in awareness regarding heart failure treatment. Major trends in the forecast period include focus on lengthening effective life of VADs, miniaturization of VADs, advanced pump technologies, increased focus on VAd safety and effectiveness, focus on reduction in side effects of VADs and percutaneously inserted ventricular assist devices.

The forecast of 13.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for biocompatible blood pump impellers and percutaneous drive line components, sourced from key regions such as Sweden and the United Kingdom, could lead to shortages in life-saving heart failure support systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cardiovascular disorders is driving growth in the ventricular assist device market. Cardiovascular disorders, which include heart diseases caused by factors such as high blood pressure, smoking, high cholesterol, and inactivity, are increasingly common. The prevalence of these conditions is further exacerbated by non-communicable diseases like diabetes, chronic respiratory illnesses, and heart attacks linked to hypertension. As the incidence of cardiovascular disorders rises, so does the demand for ventricular assist devices, which serve as crucial support systems for severely ill cardiac patients. For instance, in October 2022, the National Library of Medicine, a US-based federal agency, projected that by 2035, 45.1% of the US population will have cardiovascular disease, with total costs associated with these diseases expected to reach $1.1 trillion. Consequently, the increasing prevalence of cardiovascular disorders is anticipated to significantly boost demand for ventricular assist devices during the forecast period.

The increased awareness surrounding heart failure treatment is a pivotal factor expected to fuel the growth of the ventricular assist device market. Heart failure, characterized by the heart's diminished ability to effectively pump blood, can result from conditions such as coronary artery disease, heart attacks, high blood pressure, and heart muscle damage. The escalating awareness about heart failure treatments is anticipated to drive the adoption of ventricular assist devices as a means to address heart failure. Notably, the American Heart Association projects a 46% increase in heart failure diagnoses by 2030, surpassing 8 million individuals affected. As the number of people diagnosed with heart failure continues to rise, the heightened awareness of available treatment options is poised to be a key driver for the ventricular assist device market.

The adoption of percutaneously inserted ventricular assist devices is gaining prominence in the market. Percutaneously inserted ventricular assist devices are non-pulsatile axial flow pumps positioned across the aortic valve, pumping blood from the left ventricle. These devices alleviate the load on the left ventricle, decrease myocardial oxygen consumption, enhance cardiac output, and reduce left ventricular end-diastolic pressure. As an example, in August 2022, Abiomed Inc., a US-based medical device company, introduced the Impella, a percutaneous VAD designed for eligible pediatric patients in the USA. The Impella device provides effective cardiac support to compensate for a failing left ventricle and can serve as an alternative to extracorporeal membrane oxygenation (ECMO) or complement other therapies to enhance hemodynamics.

In August 2022, Medtronic PLC, an Ireland-based medical device company, acquired Affera, Inc. for $925 million. This strategic acquisition broadens Medtronic's portfolio of cardiac ablation products, introducing their initial cardiac mapping and navigation platform. The platform includes radiofrequency ablation, focal pulsed field, and an integrated diagnostic solution. Affera Inc., a US-based medical technology company, specializes in cardiac mapping and navigation systems, along with catheter-based cardiac ablation technologies.

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ventricular assist device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The ventricular assist device market consists of sales of pulsatile and nonpulsatile LVADs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ventricular Assist Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ventricular assist device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ventricular assist device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ventricular assist device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).
  • 2) By Type: Pulsatile Flow, Continuous Flow
  • 3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
  • 4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
  • 5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres
  • Subsegments:
  • 1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs; Temporary LVADs
  • 2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs; Temporary RVADs
  • 3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs; Hybrid BIVADs
  • Companies Mentioned: Abiomed; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation; Berlin Heart GmbH; Cirtec; Jarvik Heart Inc.; SynCardia Systems LLC.; Calon Cardio-Technology Ltd; Huadong Medicine Co. Ltd; Shenzhen Hexin Zondan Medical Equipment Co. Ltd; Sun Medical Technology Research Corp.; Boston Scientific Corporation; CorWave SA; CH Biomedical (USA) Inc; Evaheart Inc; BiVACOR Inc; ReliantHeart Inc; Cardiac Assist Inc; Heart Ware International; Braile Biomedica Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ventricular Assist Device Market Characteristics

3. Ventricular Assist Device Market Trends And Strategies

4. Ventricular Assist Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ventricular Assist Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ventricular Assist Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ventricular Assist Device Market Growth Rate Analysis
  • 5.4. Global Ventricular Assist Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ventricular Assist Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ventricular Assist Device Total Addressable Market (TAM)

6. Ventricular Assist Device Market Segmentation

  • 6.1. Global Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)
  • 6.2. Global Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pulsatile Flow
  • Continuous Flow
  • 6.3. Global Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices
  • 6.4. Global Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bridge-to-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge-to-Recovery (BTR) Therapy
  • Bridge-to-Candidacy (BTC) Therapy
  • 6.5. Global Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiology Centers
  • 6.6. Global Ventricular Assist Device Market, Sub-Segmentation Of Left Ventricular Assist Devices (LVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable LVADs
  • Temporary LVADs
  • 6.7. Global Ventricular Assist Device Market, Sub-Segmentation Of Right Ventricular Assist Devices (RVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable RVADs
  • Temporary RVADs
  • 6.8. Global Ventricular Assist Device Market, Sub-Segmentation Of Biventricular Assist Devices (BIVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Full Support BIVADs
  • Hybrid BIVADs

7. Ventricular Assist Device Market Regional And Country Analysis

  • 7.1. Global Ventricular Assist Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ventricular Assist Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ventricular Assist Device Market

  • 8.1. Asia-Pacific Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ventricular Assist Device Market

  • 9.1. China Ventricular Assist Device Market Overview
  • 9.2. China Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ventricular Assist Device Market

  • 10.1. India Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ventricular Assist Device Market

  • 11.1. Japan Ventricular Assist Device Market Overview
  • 11.2. Japan Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ventricular Assist Device Market

  • 12.1. Australia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ventricular Assist Device Market

  • 13.1. Indonesia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ventricular Assist Device Market

  • 14.1. South Korea Ventricular Assist Device Market Overview
  • 14.2. South Korea Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ventricular Assist Device Market

  • 15.1. Western Europe Ventricular Assist Device Market Overview
  • 15.2. Western Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ventricular Assist Device Market

  • 16.1. UK Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ventricular Assist Device Market

  • 17.1. Germany Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ventricular Assist Device Market

  • 18.1. France Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ventricular Assist Device Market

  • 19.1. Italy Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ventricular Assist Device Market

  • 20.1. Spain Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ventricular Assist Device Market

  • 21.1. Eastern Europe Ventricular Assist Device Market Overview
  • 21.2. Eastern Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ventricular Assist Device Market

  • 22.1. Russia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ventricular Assist Device Market

  • 23.1. North America Ventricular Assist Device Market Overview
  • 23.2. North America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ventricular Assist Device Market

  • 24.1. USA Ventricular Assist Device Market Overview
  • 24.2. USA Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ventricular Assist Device Market

  • 25.1. Canada Ventricular Assist Device Market Overview
  • 25.2. Canada Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ventricular Assist Device Market

  • 26.1. South America Ventricular Assist Device Market Overview
  • 26.2. South America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ventricular Assist Device Market

  • 27.1. Brazil Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ventricular Assist Device Market

  • 28.1. Middle East Ventricular Assist Device Market Overview
  • 28.2. Middle East Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ventricular Assist Device Market

  • 29.1. Africa Ventricular Assist Device Market Overview
  • 29.2. Africa Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ventricular Assist Device Market Competitive Landscape And Company Profiles

  • 30.1. Ventricular Assist Device Market Competitive Landscape
  • 30.2. Ventricular Assist Device Market Company Profiles
    • 30.2.1. Abiomed Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Ventricular Assist Device Market Other Major And Innovative Companies

  • 31.1. Berlin Heart GmbH
  • 31.2. Cirtec
  • 31.3. Jarvik Heart Inc.
  • 31.4. SynCardia Systems LLC.
  • 31.5. Calon Cardio-Technology Ltd
  • 31.6. Huadong Medicine Co. Ltd
  • 31.7. Shenzhen Hexin Zondan Medical Equipment Co. Ltd
  • 31.8. Sun Medical Technology Research Corp.
  • 31.9. Boston Scientific Corporation
  • 31.10. CorWave SA
  • 31.11. CH Biomedical (USA) Inc
  • 31.12. Evaheart Inc
  • 31.13. BiVACOR Inc
  • 31.14. ReliantHeart Inc
  • 31.15. Cardiac Assist Inc

32. Global Ventricular Assist Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ventricular Assist Device Market

34. Recent Developments In The Ventricular Assist Device Market

35. Ventricular Assist Device Market High Potential Countries, Segments and Strategies

  • 35.1 Ventricular Assist Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ventricular Assist Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ventricular Assist Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer